uniQure is focused on the research and early development of human gene-based therapies. It develops treatment and platform for patients suffering from genetic and other devastating diseases. The Company's products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases.
|Employees (est.) (Dec 2018)||212||(+5%)|
|Share Price (Mar 2020)||$44.3||(-1%)|
Market capitalization (27-Mar-2020)
Closing stock price (27-Mar-2020)
UniQure has 1.77k Twitter Followers. The number of followers has increased 1.5% month over month and increased 9.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was UniQure founded?
UniQure was founded in 1998.
Who are UniQure key executives?
UniQure's key executives are Jack Kaye, Matt Kapusta and Jonathan Garen.
How many employees does UniQure have?
UniQure has 212 employees.
Who are UniQure competitors?
Competitors of UniQure include Atara Biotherapeutics, GeneQuine Biotherapeutics and IntraBio.
Where is UniQure headquarters?
UniQure headquarters is located at Paasheuvelweg 25a, Amsterdam.
Where are UniQure offices?
UniQure has an office in Amsterdam.
How many offices does UniQure have?
UniQure has 1 office.
Receive alerts for 300+ data fields across thousands of companies